Where does Martin Heidecker work?

Martin Heidecker is Chief Investment Officer at AMR Action Fund.

What boards does Martin Heidecker sit on?

Martin Heidecker holds tracked board seats at Abexxa Biologics, Adaptive Phage Therapeutics, Elion Therapeutics, Rgenta Therapeutics, Vedanta Biosciences, Venatorx Pharmaceuticals.

Where did Martin Heidecker go to school?

Martin Heidecker studied at The Julius Maximilians University of Würzburg (Doctor of Philosophy (PhD), Biology).

Martin Heidecker

Investor

Chief Investment Officer at AMR Action Fund

Cambridge, Massachusetts, United States

About

Joined the fund in 2021 with extensive venture capital and drug development experience. Previously Managing Director USA of Boehringer Ingelheim Venture Fund and began his investing career at Bayern Kapital in Germany.

Contact· self-published, not guessed

m•••@amractionfund.comreveal

Experience

AMR Action FundChief Investment Officercurrent2021 — presentBoston, Massachusetts, United States
AMR Action FundMember Board of Directors AMR action2020 — 2021
MassBioBoard Member MassBio Biotechnologycurrent2020 — presentCambridge, Massachusetts, United States
Libra TherapeuticsMember Board of Directors Libra Therapeutics Inc.2020 — 2021San Diego, California, United States
Tiga Therapeutics Inc.Member Board of Directors Tiga Tx Inc.2020 — 2021Cambridge, Massachusetts, United States
Rgenta Therapeutics Inc.Member Board of Directors Rgenta Therapeutics Inc.2020 — 2021Cambridge, Massachusetts, United States
Abexxa Biologics, Inc.Member Board of Directors Abexxa Biologics Inc.2016 — 2021Arlington, Texas, United States
Sentien Biotechnologies, Inc.Member Board of Directors2015 — 2021Medford, MA
Boehringer Ingelheim Venture Fund USA Inc.Managing Director BIVF USA Inc.2013 — 2021Cambridge, Massachusetts
ArmaGen TechnologiesMember Board of Directors2012 — 2020Calabasis, California
121 Bio LLCMember Board of Directors2014 — 2016Cambridge, MA
AMP TherapeuticsMember Board of Directors2012 — 2015Leipzig Area, Germany
Boehringer IngelheimDirector, Investment Manager2010 — 2013Ingelheim, Germany
Boehringer IngelheimTeam Leader Business Analysis CNS&Oncology2009 — 2010Ingelheim, Germany
Boehringer IngelheimSenior International Manager Business Analysis2007 — 2009
Solvay Pharmaceuticals GmbH - Solvay HQSenior Global Business Analyst2004 — 2007
Solvay PharmaceuticalsGlobal Business Analyst2004 — 2007
DEWB, BayernkapitalInvestment Manager2001 — 2004

Skills & more

Oncology46Biotechnology51Market Research32Lifesciences12Clinical Development21Market Access12Biopharmaceuticals19Business Analysis9Drug Discovery10Neurology7Market Analysis14Pharmaceutical Sales8

+12 more

Drug DevelopmentTechnology TransferGlobal MarketingSales EffectivenessCompetitive IntelligenceCardiologyClinical TrialsCommercializationPharmaceutical IndustryMedical DevicesVaccinesDiabetes

From Martin's professional profile.

Deals · 4

Vedanta BiosciencesBoard seat

via AMR Action Fund · filed Aug 2024 · $118.5M raise

Adaptive Phage TherapeuticsBoard seat

via AMR Action Fund · filed Jun 2023 · $30M raise

Rgenta TherapeuticsBoard seat

via AMR Action Fund · filed Mar 2021 · $38M raise

Abexxa BiologicsBoard seat

via AMR Action Fund · filed Sep 2016 · $1.7M raise

Attribution from SEC filings, press coverage, and firm rosters.

Other disclosed investments

Board seats

Elion TherapeuticsVenatorx Pharmaceuticals

Per SEC Form D filings.

Colleagues at AMR Action Fund

Bill Burns

Board Chair at AMR Action Fund

Carly Levine

Senior Associate at AMR Action Fund

Chris Sweeney

Executive Director, Communications and Media Relations at AMR Action Fund

Corinna Ruppli

Office Manager at AMR Action Fund

David Hellmuth

General Counsel and COO at AMR Action Fund

Deepali Patel

Director of International Policy at AMR Action Fund

Dorothy Maloney

Compliance Officer at AMR Action Fund

Henni-Karoliina Ropponen

Venture Analyst at AMR Action Fund

Frequently asked questions

Who is Martin Heidecker?: Joined the fund in 2021 with extensive venture capital and drug development experience. Previously Managing Director USA of Boehringer Ingelheim Venture Fund and began his investing career at Bayern Kapital in Germany.
Where does Martin Heidecker work?: Martin Heidecker is Chief Investment Officer at AMR Action Fund.
What boards does Martin Heidecker sit on?: Martin Heidecker holds tracked board seats at Abexxa Biologics, Adaptive Phage Therapeutics, Elion Therapeutics, Rgenta Therapeutics, Vedanta Biosciences, Venatorx Pharmaceuticals.
Where did Martin Heidecker go to school?: Martin Heidecker studied at The Julius Maximilians University of Würzburg (Doctor of Philosophy (PhD), Biology).